MedTrace Logo

The Effect of Intraurethral Lidocaine Gel on Pain Perception During Flexible Cystoscopy

NCT03874364 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2019-03-14

No results posted yet for this study

Summary

Flexible cystoscopy is routinely performed by urologists. Many patients have concerns to undergo this procedure and expect it to be unpleasant or even painful. Thus, reduction of pain and discomfort during cystoscopy is of great interest, but there is not sufficient evidence regarding the most appropriate conduct of cystoscopy.

In this study the impact of lidocaine gel, patient counseling and monitoring regarding pain perception during flexible cystoscopy are investigated.

Conditions

  • Flexible Cystoscopy

Interventions

DEVICE

Lidocaine gel

10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.

OTHER

Counselling

Patients receive a brochure in the waiting room explaining the procedure in details.

OTHER

Monitor

Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.

DEVICE

Lubricating gel

10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.

OTHER

No counselling

Patients won't receive a brochure in the waiting room explaining the procedure in details.

OTHER

No monitor

Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.

Sponsors & Collaborators

  • Ajet Hyseni

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03874364 on ClinicalTrials.gov